USA: A recent study published in Diabetes Technology & Therapeutics has highlighted the advantages of integrating FreeStyle ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.

Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, ...

But now, Abbott’s FreeStyle Libre 2 and 3 have received the first and only FDA clearance that allows patients to keep their ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Abbott's FreeStyle Libre 2 and 3 continuous glucose monitors no longer need to be removed for imaging tests. CGM readings during an MRI may be affected for up to an hour after the procedure. While ...

GOOD TRY (Freestyle): There's no theme today ... Congratulations to Steve Johnson making a USA TODAY debut! Additionally, congratulations to Darby Ratliff making a USA TODAY editing debut!

The company’s key products include medical devices like FreeStyle Libre for glucose monitoring and MitraClip for heart valve repair, point-of-care testing systems and infectious disease testing ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...